Takeda Pharmaceuticals U.S.A., Inc.'s Net Worth

$128 Million

Who is Takeda Pharmaceuticals U.S.A., Inc.?

Takeda Pharmaceuticals U.S.A., Inc. has an estimated net worth of $128 Million. This is based on reported shares across multiple companies, which include Molecular Templates, Inc., Cortexyme, Inc., Myovant Sciences Ltd., Ovid Therapeutics Inc., and Day One Biopharmaceuticals, Inc..

SEC CIK

Takeda Pharmaceuticals U.S.A., Inc.'s CIK is 0001716229

Past Insider Trading and Trends

2022 was Takeda Pharmaceuticals U.S.A., Inc.'s most active year for acquiring shares with 2 total transactions. Takeda Pharmaceuticals U.S.A., Inc.'s most active month to acquire stocks was the month of June. 2021 was Takeda Pharmaceuticals U.S.A., Inc.'s most active year for disposing of shares, totalling 5 transactions. Takeda Pharmaceuticals U.S.A., Inc.'s most active month to dispose stocks was the month of November. 2022 saw Takeda Pharmaceuticals U.S.A., Inc. paying a total of $0.00 for 5,751,250 shares, this is the most they've acquired in one year. In 2021 Takeda Pharmaceuticals U.S.A., Inc. cashed out on 407,482 shares for a total of $7,491,399.08, their largest year based on trade value.